Tag: SARAH
SIRT significantly better tolerated than sorafenib, but does not increase overall...
The 459-patient randomised controlled SARAH study shows that local treatments of advanced or inoperable hepatocellular carcinoma with selective internal radiation therapy (SIRT) did not...
SARAH study results to be presented as oral abstract at April...
Sirtex has announced that the SARAH (Sorafenib vs. radioembolisation in advanced hepatocellular carcinoma) randomised controlled study results will be presented at the upcoming European...
